viralic
Forumer storico
altra acquisizione con premio quasi del 100% rispetto al prezzo di borsa.....ormai questa è la regola !!
Urovant Sciences (NASDAQ:UROV) shares have spiked after hours, currently trading up 90% to $15.75 on news that Sumitovant Biopharma will acquire the outstanding shares of Urovant not already owned by Sumitovant at a price of $16.25 per share in cash. Sumitovant currently owns 72% of Urovant common stock.
Urovant Sciences (NASDAQ:UROV) shares have spiked after hours, currently trading up 90% to $15.75 on news that Sumitovant Biopharma will acquire the outstanding shares of Urovant not already owned by Sumitovant at a price of $16.25 per share in cash. Sumitovant currently owns 72% of Urovant common stock.